Stay Connected. Stay Informed.
A panel discussion on ‘Building Innovation-First GCCs: AI, R&D & Digital Transformation’ was organised as part of BioAsia 2026 in Hyderabad on Wednesday (February 18, 2025) | Photo Credit: Siddhant Thakur Hyderabad is emerging as a key hub for building artificial intelligence-driven capabilities for global pharmaceutical and medical technology companies, with several multinational firms developing…
Collaboration between Australia and India in life sciences and biotechnology is beginning to yield early results following the Australia-India Economic Cooperation and Trade Agreement, with Queensland positioning itself as a key partner for Indian companies and institutions across clinical research, translational science and healthcare innovation. This momentum was highlighted during an exclusive media roundtable held…
(From left) Winselow Tucker (president and GM of Lilly India), Stefan Miltenyi (founder CEO and president of Miltenyi Biotec, Germany), G.V.Prasad (co-chairman & MD of Dr. Reddy’s Laboratories), Eric Mansion (GM, India & South-East Asia of Sanofi, Singapore) and Shreehas Tambe (MD and CEO of Biocon Biologics) at a panel discussion during BioAsia 2026 in…
Read More “India’s capacity to scale next-generation biologics draws focus at BioAsia 2026” »
